Search company, investor...

Elekta - Magnetoencephalography (MEG) Business


Acquired Unit | Acquired

About Elekta - Magnetoencephalography (MEG) Business

Elekta is a human-care company focused on clinical solutions for treating cancer and brain disorders. The company develops tools and treatment-planning systems for radiation therapy and radiosurgery, as well as workflow-enhancing software systems across the spectrum of cancer care. Elekta aims to improve, prolong and even save patient lives, making the future possible today. MEG is a diagnostic functional neuroimaging technique for mapping brain activity. This can be applied in a clinical setting to find locations of abnormalities as well as in a research setting to simply measure brain activity. Elekta's MEG business, known as MEGIN, is a leading supplier of magnetoencephalography (MEG) technology, with more than 100 delivered MEG systems worldwide.

Headquarters Location

Kungstensgatan 18

Stockholm, 103 93,


+46 8587 254 00



Elekta - Magnetoencephalography (MEG) Business Frequently Asked Questions (FAQ)

  • Where is Elekta - Magnetoencephalography (MEG) Business's headquarters?

    Elekta - Magnetoencephalography (MEG) Business's headquarters is located at Kungstensgatan 18, Stockholm.

  • What is Elekta - Magnetoencephalography (MEG) Business's latest funding round?

    Elekta - Magnetoencephalography (MEG) Business's latest funding round is Acquired Unit.

  • Who are the investors of Elekta - Magnetoencephalography (MEG) Business?

    Investors of Elekta - Magnetoencephalography (MEG) Business include York Instruments.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.